Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Timothy Ashby

Concepts (199)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
38
2024
2990
2.720
Why?
High-Throughput Nucleotide Sequencing
7
2022
162
1.160
Why?
Genomics
10
2023
238
0.870
Why?
Mutation
14
2022
1275
0.850
Why?
Software
4
2021
268
0.840
Why?
Tumor Microenvironment
4
2024
221
0.600
Why?
Clonal Evolution
4
2020
56
0.570
Why?
Plasma Cells
6
2023
220
0.560
Why?
Computational Biology
4
2020
194
0.540
Why?
Gene Expression Regulation, Neoplastic
6
2024
831
0.520
Why?
Algorithms
4
2020
624
0.490
Why?
Neoplasm Recurrence, Local
5
2024
622
0.460
Why?
Monoclonal Gammopathy of Undetermined Significance
3
2024
112
0.440
Why?
Neoplasms
2
2020
1248
0.400
Why?
Humans
45
2024
50419
0.390
Why?
Hematopoietic Stem Cell Transplantation
3
2024
580
0.380
Why?
Osteolysis
2
2022
74
0.380
Why?
Models, Molecular
1
2013
333
0.370
Why?
Gene Expression Profiling
9
2023
1020
0.350
Why?
Chromosome Aberrations
3
2023
279
0.350
Why?
Genome, Human
3
2021
108
0.350
Why?
Evolution, Molecular
2
2021
86
0.350
Why?
Osteocytes
2
2024
225
0.340
Why?
Signal Transduction
4
2024
1608
0.340
Why?
Proteins
1
2013
340
0.330
Why?
Prognosis
11
2024
1974
0.330
Why?
Bone Marrow
3
2020
360
0.310
Why?
Antineoplastic Combined Chemotherapy Protocols
4
2020
997
0.270
Why?
RANK Ligand
2
2024
186
0.260
Why?
Disease Progression
7
2023
825
0.240
Why?
Gene Rearrangement
2
2023
63
0.240
Why?
Chemokine CCL3
1
2024
13
0.230
Why?
HMGB1 Protein
1
2024
21
0.230
Why?
Translocation, Genetic
6
2022
236
0.230
Why?
Chemokine CXCL12
1
2024
33
0.220
Why?
Bone Resorption
2
2024
301
0.220
Why?
Burkitt Lymphoma
1
2023
14
0.210
Why?
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
1
2023
11
0.200
Why?
Gene Dosage
2
2020
73
0.200
Why?
Epigenesis, Genetic
3
2023
371
0.200
Why?
Proto-Oncogene Proteins c-akt
1
2023
155
0.200
Why?
Drug Resistance, Neoplasm
1
2024
315
0.190
Why?
Proto-Oncogene Proteins B-raf
2
2020
80
0.190
Why?
Neoplasm Proteins
2
2021
320
0.190
Why?
Oncogenes
2
2020
54
0.190
Why?
Mice
8
2024
5659
0.190
Why?
Cell Communication
1
2022
70
0.190
Why?
Telomere Homeostasis
1
2021
10
0.180
Why?
Ubiquitination
1
2021
42
0.180
Why?
Polycomb Repressive Complex 2
1
2021
46
0.180
Why?
Chromosome Deletion
2
2023
134
0.180
Why?
Loss of Heterozygosity
2
2018
75
0.180
Why?
Lymphoma, B-Cell
1
2021
49
0.180
Why?
Positron-Emission Tomography
2
2022
290
0.180
Why?
Sequence Analysis, DNA
2
2018
194
0.170
Why?
Genes, Tumor Suppressor
2
2021
73
0.170
Why?
B-Lymphocytes
1
2021
171
0.170
Why?
Cell Cycle
1
2021
227
0.170
Why?
Cell Cycle Proteins
1
2021
163
0.170
Why?
Lymphoma, Follicular
1
2020
20
0.170
Why?
Cell Line, Tumor
4
2024
1393
0.170
Why?
Exosome Multienzyme Ribonuclease Complex
1
2020
12
0.170
Why?
Leukemia, Plasma Cell
1
2020
32
0.170
Why?
Gene Regulatory Networks
1
2020
106
0.160
Why?
Genes, myc
1
2019
33
0.160
Why?
Tumor Suppressor Protein p53
2
2017
212
0.150
Why?
Transplantation, Autologous
4
2024
480
0.150
Why?
Mutagenesis
1
2018
58
0.150
Why?
Diffusion Magnetic Resonance Imaging
1
2018
124
0.140
Why?
Genome
1
2018
57
0.140
Why?
Neoplasm, Residual
1
2018
161
0.140
Why?
Homologous Recombination
1
2018
41
0.140
Why?
Female
11
2024
27053
0.140
Why?
Chromosomes, Human, Pair 17
1
2017
34
0.140
Why?
Animals
8
2024
13063
0.140
Why?
Survival Rate
4
2021
906
0.140
Why?
Transcriptome
2
2020
314
0.140
Why?
DNA Repair
1
2018
187
0.130
Why?
Flow Cytometry
1
2018
472
0.130
Why?
DNA Copy Number Variations
3
2022
109
0.120
Why?
Aged
8
2021
9738
0.120
Why?
Epigenomics
1
2015
65
0.120
Why?
Aged, 80 and over
5
2021
3233
0.120
Why?
Remission Induction
3
2021
208
0.120
Why?
Genes, Neoplasm
1
2015
27
0.120
Why?
Pattern Recognition, Automated
1
2015
40
0.120
Why?
Male
11
2024
25866
0.110
Why?
Cluster Analysis
1
2015
209
0.110
Why?
Middle Aged
8
2021
12579
0.110
Why?
Follow-Up Studies
4
2021
2231
0.110
Why?
Databases, Protein
1
2013
28
0.100
Why?
Protein Structure, Secondary
1
2013
71
0.100
Why?
Sequence Alignment
1
2013
115
0.100
Why?
Amino Acid Sequence
1
2013
575
0.090
Why?
T-Lymphocytes
2
2024
325
0.090
Why?
Adenocarcinoma
1
2015
396
0.090
Why?
Breast Neoplasms
1
2020
1198
0.090
Why?
Mutation Rate
2
2021
35
0.090
Why?
In Situ Hybridization, Fluorescence
2
2023
231
0.090
Why?
Tumor Burden
2
2020
130
0.090
Why?
Alleles
2
2021
252
0.080
Why?
Adult
6
2021
13561
0.080
Why?
Clone Cells
2
2021
72
0.080
Why?
Proto-Oncogene Proteins p21(ras)
2
2021
67
0.080
Why?
Lung Neoplasms
1
2015
597
0.080
Why?
DNA, Neoplasm
2
2020
144
0.080
Why?
DNA Mutational Analysis
2
2020
175
0.080
Why?
Treatment Outcome
4
2020
5265
0.070
Why?
DNA Methylation
2
2023
548
0.070
Why?
Recurrence
2
2021
657
0.070
Why?
Genomic Instability
2
2018
90
0.070
Why?
Risk Factors
3
2021
3712
0.060
Why?
Cell Proliferation
2
2021
980
0.060
Why?
Internet
2
2018
259
0.060
Why?
Ferritins
1
2024
30
0.050
Why?
Killer Cells, Natural
1
2024
107
0.050
Why?
Myeloid Progenitor Cells
1
2023
17
0.050
Why?
CD8-Positive T-Lymphocytes
1
2024
127
0.050
Why?
Xenograft Model Antitumor Assays
1
2024
210
0.050
Why?
Antibodies
1
2024
151
0.050
Why?
Proteasome Inhibitors
1
2024
104
0.050
Why?
Integrin beta Chains
1
2023
13
0.050
Why?
Integrins
1
2023
29
0.050
Why?
Oxidative Phosphorylation
1
2023
41
0.050
Why?
Cytogenetic Analysis
1
2023
74
0.050
Why?
B-Cell Maturation Antigen
1
2024
98
0.050
Why?
TNF Receptor-Associated Factor 3
1
2022
13
0.050
Why?
Cystatin M
1
2022
19
0.050
Why?
Chromosomes, Human, Pair 1
1
2023
92
0.050
Why?
Immunoglobulins
1
2023
80
0.050
Why?
Forkhead Transcription Factors
1
2023
110
0.050
Why?
Chromatin
1
2023
133
0.050
Why?
Phylogeny
1
2022
195
0.050
Why?
Syndecan-1
1
2021
73
0.050
Why?
Spliceosomes
1
2021
10
0.050
Why?
Transcriptional Activation
1
2021
120
0.040
Why?
RNA Splicing
1
2021
38
0.040
Why?
Alternative Splicing
1
2021
54
0.040
Why?
Cyclin D2
1
2020
20
0.040
Why?
Spatio-Temporal Analysis
1
2020
8
0.040
Why?
Aneuploidy
1
2020
18
0.040
Why?
Proto-Oncogene Proteins c-maf
1
2020
19
0.040
Why?
Chromosomes, Human, Pair 4
1
2020
30
0.040
Why?
Chromosomes, Human, Pair 11
1
2020
49
0.040
Why?
Histone Code
1
2020
30
0.040
Why?
Ecosystem
1
2021
63
0.040
Why?
Gene Expression Regulation, Leukemic
1
2020
29
0.040
Why?
Cyclin D1
1
2020
52
0.040
Why?
ras Proteins
1
2020
65
0.040
Why?
Chromosomes, Human, Pair 14
1
2020
66
0.040
Why?
Phosphoproteins
1
2021
116
0.040
Why?
Single-Cell Analysis
1
2020
63
0.040
Why?
Mice, Transgenic
1
2021
537
0.040
Why?
Cell Differentiation
1
2022
640
0.040
Why?
Genetic Variation
1
2020
197
0.040
Why?
DNA
1
2023
534
0.040
Why?
Protein Disulfide-Isomerases
1
2019
14
0.040
Why?
Melphalan
1
2020
177
0.040
Why?
Genes, Immunoglobulin Heavy Chain
1
2019
12
0.040
Why?
Neoplasm Invasiveness
1
2020
269
0.040
Why?
Osteoclasts
1
2022
427
0.040
Why?
Osteogenesis
1
2022
354
0.040
Why?
Multivariate Analysis
1
2021
583
0.040
Why?
Combined Modality Therapy
1
2021
640
0.040
Why?
Disease Models, Animal
1
2024
1431
0.040
Why?
Maintenance Chemotherapy
1
2019
48
0.040
Why?
Apoptosis
1
2024
1092
0.040
Why?
Cell Survival
1
2020
587
0.040
Why?
Histones
1
2020
294
0.040
Why?
Promoter Regions, Genetic
1
2020
455
0.040
Why?
25-Hydroxyvitamin D3 1-alpha-Hydroxylase
1
2017
8
0.040
Why?
Cyclin-Dependent Kinase Inhibitor p18
1
2017
27
0.040
Why?
Genome-Wide Association Study
1
2018
163
0.030
Why?
Reproducibility of Results
1
2021
1181
0.030
Why?
STAT3 Transcription Factor
1
2017
77
0.030
Why?
Information Dissemination
1
2018
77
0.030
Why?
Fibroblast Growth Factors
1
2017
46
0.030
Why?
Mitogen-Activated Protein Kinases
1
2017
154
0.030
Why?
Prospective Studies
1
2023
2378
0.030
Why?
Dose-Response Relationship, Drug
1
2020
1369
0.030
Why?
Thalidomide
1
2019
375
0.030
Why?
Proportional Hazards Models
1
2018
416
0.030
Why?
Genes, ras
1
2016
43
0.030
Why?
Kaplan-Meier Estimate
1
2018
462
0.030
Why?
Genes, p53
1
2016
49
0.030
Why?
Cohort Studies
1
2020
1451
0.030
Why?
Models, Genetic
1
2016
166
0.030
Why?
Antineoplastic Agents
1
2024
1165
0.030
Why?
Phosphatidylinositol 3-Kinases
1
2016
139
0.030
Why?
Survival Analysis
1
2017
658
0.030
Why?
Stem Cell Transplantation
1
2016
179
0.030
Why?
Dogs
1
2015
185
0.030
Why?
Databases, Genetic
1
2015
77
0.030
Why?
Time Factors
1
2021
2933
0.030
Why?
Sequence Analysis, RNA
1
2015
87
0.030
Why?
Genetic Testing
1
2015
120
0.030
Why?
Longitudinal Studies
1
2016
732
0.030
Why?
Retrospective Studies
1
2024
6274
0.020
Why?
Child
1
2023
6931
0.020
Why?
Ashby's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description